Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial

Ke-Da Yu (1) , Xi-Yu Liu , Li Chen , Miao Mo , Jiong Wu , Guang-Yu Liu , Gen-Hong Di , Claire Verschraegen , Daniel Stover , Zhi-Gang Zhuang , F. Bertucci (2) , Armando Orlandi , Jie Wang (3) , Giuseppe Lippi (4) , Ke-Jin Wu , Mohammed Osman (5) , Lei Fan (6) , Zhi-Ming Shao (1)

1 Fudan University Shanghai Cancer Center [China]
2 CRCM - Centre de Recherche en Cancérologie de Marseille
3 AMSS - Academy of Mathematics and Systems Science
4 University Hospital of Verona
5 CIMMS - Cooperative Institute for Mesoscale Meteorological Studies
6 Southwest University [Chongqing]

Domains: Life Sciences [q-bio]; Cancer

Ke-Da Yu, Xi-Yu Liu, Li Chen, Miao Mo, Jiong Wu, et al.. Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial. The Lancet Regional Health - Western Pacific, 2021, 11, pp.100158. ⟨10.1016/j.lanwpc.2021.100158⟩. ⟨hal-03623636⟩